PRP Therapy Protocols Lack Expert Consensus

Key Takeaways

• Experts disagree on NSAID avoidance ranging from 48 hours to six weeks
• Corticosteroid washout periods vary between two weeks and two months
• Cryotherapy recommendations span prohibition to use after 48 hours
• Rehab start times differ from one to three weeks post‑injection
• Lack of consensus hampers outcome tracking and patient adherence

Pulse Analysis

The surge in platelet‑rich plasma (PRP) injections for musculoskeletal injuries has outpaced the development of consistent clinical pathways. While PRP’s mechanism—triggering a controlled inflammatory response to promote tissue repair—remains widely accepted, the surrounding peri‑procedural steps are anything but. Practitioners across orthopedics, sports medicine, and pain management prescribe divergent NSAID washout periods, supplement discontinuations, and even basic pre‑procedure instructions such as fasting or skin preparation. This fragmentation stems from limited high‑quality trials and a reliance on specialty tradition, leaving clinicians to navigate a patchwork of expert opinions rather than a unified evidence base.

The consequences of this variability extend beyond practitioner inconvenience. Patients frequently encounter conflicting handouts, leading to confusion, reduced adherence, and skepticism toward regenerative therapies. Moreover, the lack of standardized protocols impedes robust outcome research; disparate post‑injection regimens make it difficult to compare efficacy across studies or institutions. As a result, the field struggles to demonstrate definitive cost‑effectiveness or long‑term benefits, slowing insurance coverage and broader market acceptance.

Addressing the gap requires coordinated action from specialty societies, academic researchers, and industry stakeholders. Developing interdisciplinary consensus statements—grounded in systematic reviews and updated as new data emerge—can provide clear guidance on NSAID timing, corticosteroid washout, cryotherapy use, and rehabilitation milestones. Embedding these protocols into electronic health records and continuing‑education curricula will promote uniform adoption, enhance patient trust, and generate comparable data sets for future meta‑analyses. In short, standardization is the linchpin that will unlock PRP’s full potential in regenerative medicine.